Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 18. Juli 2024
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8035  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 160683  
   
Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis.
BJUI Compass
Zhou Y, Lyratzopoulos G, Rajan P, Walter FM, Wu J.
PMID: 39022664 [PubMed]


Comparison of staging MRI to re-resection for localised bladder cancer: Narrative review.
BJUI Compass
Klempfner H, Anderson P.
PMID: 39022656 [PubMed]


Corrigendum to "Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory biopsy study" [Eur. J. Radiol. Open 11 (2023) 100529].
Eur J Radiol Open
Velaga J, Tay KJ, Hang G, Tan YG, Yuen JSP, Chua MLK, Gupta RT, Polascik TJ, Ngo NT, Law YM.
PMID: 39022615 [PubMed]


The impact of androgen deprivation therapy on bone microarchitecture in men with prostate cancer: A longitudinal observational study (The ANTELOPE Study).
J Bone Oncol
Handforth C, Paggiosi MA, Jacques R, Gossiel F, Eastell R, Walsh JS, Brown JE.
PMID: 39021590 [PubMed]


The 30th Annual Prostate Cancer Foundation Scientific Retreat Report.
Prostate
Miyahira AK, Soule HR.
PMID: 39021296 [PubMed - as supplied by publisher]


PROTAC'ing the androgen receptor and other emerging therapeutics in prostate cancer.
Expert Rev Anticancer Ther
Zang PD, Seylani A, Yu EY, Dorff TB.
PMID: 39021245 [PubMed - as supplied by publisher]


Significance of androgen-deprivation therapy for intermediate- and high-risk prostate cancer treated with high-dose radiotherapy: A literature review.
Int J Urol
Aizawa R, Ishikawa H, Kato M, Shimizu S, Mizowaki T, Kohjimoto Y, Hinotsu S, Hara I, working group of the Japanese Urological Association Clinical Practice Guideline for Prostate Cancer 2023.
PMID: 39021064 [PubMed - as supplied by publisher]


Discordance of retroperitoneal and thoracic histologic findings in patients with metastatic germ cell tumors at postchemotherapy residual tumor resection.
World J Surg Oncol
Che Y, Wöltjen C, Lusch A, Winter C, Trainer S, Schirren M, Sponholz S, Knoefel WT, Albers P, Hiester A.
PMID: 39020389 [PubMed - indexed for MEDLINE]


Prevalence of diabetes and hospitalization due to poor glycemic control in people with bladder cancer or renal cell carcinoma in Sweden.
BMC Urol
Andersson E, Brådvik G, Nilsson FOL, Arpegård J, Strambi A, Kollberg P, Carlsson KS.
PMID: 39020360 [PubMed - indexed for MEDLINE]


Development of a first-in-class antibody and a specific assay for α-1,6-fucosylated prostate-specific antigen.
Sci Rep
Halldórsson S, Hillringhaus L, Hojer C, Muranyi A, Schraeml M, Lange MS, Tabarés G.
PMID: 39020051 [PubMed - indexed for MEDLINE]


Prostate-specific antigen screening for prostate cancer: Diagnostic performance, clinical thresholds, and strategies for refinement.
Urol Oncol
Sundaresan VM, Smani S, Rajwa P, Renzulli J, Sprenkle PC, Kim IY, Leapman MS.
PMID: 39019723 [PubMed - as supplied by publisher]


Prediction of Prognosis and Response to Androgen Deprivation Therapy in Intermediate to High-Risk Prostate Cancer Using (18)F-FDG PET/CT Radiomics.
Acad Radiol
Qiao J, Liu B, Xin J, Shen S, Ma H, Pan S.
PMID: 39019687 [PubMed - as supplied by publisher]


Target Volume Optimization for Localized Prostate Cancer.
Pract Radiat Oncol
Patel KR, van der Heide UA, Kerkmeijer LGW, Schoots IG, Turkbey B, Citrin DE, Hall WA.
PMID: 39019208 [PubMed - as supplied by publisher]


The role of adjuvant chemotherapy after radical surgery in patients with lymph node-positive bladder cancer or locally advanced (pT3, pT4a) bladder cancer: A meta-analysis and systematic review.
Int J Surg
Chen C, Wang C, Huang H, Li H, Wen Z, Liu Y, Yang XS.
PMID: 39017737 [PubMed - as supplied by publisher]


Advanced optical imaging techniques for bladder cancer detection and diagnosis: a systematic review.
BJU Int
Remmelink MJ, Rip Y, Nieuwenhuijzen JA, Ket JCF, Oddens JR, de Reijke TM, de Bruin DM.
PMID: 39015996 [PubMed - as supplied by publisher]


Technetium-99m-methylene diphosphonate single photon emission computed tomography/computed tomography combined with prostate-specific antigen/free prostate-specific antigen ratio for bone metastasis of prostate cancer.
World J Clin Cases
He J, Zhong YP, Zhang S.
PMID: 39015893 [PubMed]


Pathological concordance rate and outcomes by subtype in advanced papillary renal cell carcinoma.
BJU Int
Tripathi A, Tangen CM, Plets M, Li X, Tretiakova M, Humphrey PA, Adeniran A, Barata PC, Gulati S, Bergerot CD, Pruthi DK, Thompson IM, Lara PN Jr, Lerner SP, Pal SK, Shuch BM.
PMID: 39014969 [PubMed - as supplied by publisher]


PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives.
Mol Cancer
Zhu Z, Jin Y, Zhou J, Chen F, Chen M, Gao Z, Hu L, Xuan J, Li X, Song Z, Guo X.
PMID: 39014460 [PubMed - indexed for MEDLINE]


Effect of metformin on incidence, recurrence, and mortality in prostate cancer patients: integrating evidence from real-world studies.
Prostate Cancer Prostatic Dis
Liu Y, Zhang Q, Huang X.
PMID: 39014063 [PubMed - as supplied by publisher]


Association of Tumor-informed Circulating Tumor DNA Detectability Before and After Radical Cystectomy with Disease-free Survival in Patients with Bladder Cancer.
Eur Urol Oncol
Sfakianos JP, Basu A, Laliotis G, Cumarasamy S, Rich JM, Kommalapati A, Glover M, Mahmood T, Tillu N, Hoimes CJ, Selig G, Kollipara R, Stewart TF, Rivero-Hinojosa S, Dutta P, Calhoun M, Sharma S, Malhotra M, ElNaggar AC, Liu MC, Ferguson JE 3rd, Diniz M, Mehrazin R, Wiklund P, Tan A, Shah S, Galsky MD.
PMID: 39013741 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 160683    Seite 1 von 8035  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1